Peripherally restricted cannabinoid type 1 receptor (CB1R) antagonist, AM6545, potentiates stress-induced hypothalamic–pituitary–adrenal axis activation via a non-CB1R mechanism-Reference-Cited by-同舟云学术

Peripherally restricted cannabinoid type 1 receptor (CB1R) antagonist, AM6545, potentiates stress-induced hypothalamic–pituitary–adrenal axis activation via a non-CB1R mechanism

Published:2020-11-20 Issue:1 Volume:72 Page:297-300
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Roberts Christopher J.^ORCID,Hillard Cecilia J.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12020-020-02549-1.pdf

Reference20 articles.

1. S.E. Nissen et al. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. JAMA 299(13), 1547–1560 (2008).

2. J. Tam et al. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. J. Clin. Investig. 120(8), 2953–2966 (2010)

3. P.A. Randall et al. The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior. Pharmacol. Biochem. Behav. 97(1), 179–184 (2010)

4. T.U.C. Järbe et al. Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats. Psychopharmacology 216(3), 355–365 (2011)

5. M.R. Boon et al. Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity. FASEB J. 28(12), 5361–5375 (2014)

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence;Addiction Biology;2023-09-13

2. Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism;Neuropsychopharmacology;2022-09-10

3. Peripheral CB1 receptor blockade acts as a memory enhancer through an adrenergic-dependent mechanism;2021-06-17